Venture capital (VC) funding for biotechnology (defined as biomedicine) is changing, according to an analysis of data from Dow Jones VentureSource. Fewer VC firms are investing in early-stage companies. In 2011, only 194 VC or corporate VC firms were involved in biotech financings, down from 313 in 2007. Funding for innovative companies declined 34.0% between […]
New product development is the primary goal for R&D efforts this year for 41% of the 409 food and beverage processors that responded to the annual Food Processing R&D survey, which was conducted in March. Product line extensions and existing-product improvement are most important for 16% and 14% of respondents, respectively. Cost control was the […]
On April 17, the EPA released final standards for the reduction of air pollution from natural gas wells that use hydraulic fracturing, or “fracking.” Well operators have until January 2015 to employ techniques to trap natural gas that seeps from wells, so it can be used or sold. In 2009, about 1.1 million US wells […]
Worldwide clean energy spending grew 6.5% in 2011 to $263 billion. Lower clean energy technology prices and increased spending helped the total installed clean energy capacity grow 17.3% to 565 GW. The Group of Twenty (G-20) countries made up 95% of total clean energy spending. China’s investment in clean energy technology grew just 1.1% but […]
Domestic and foreign R&D spending by members of the Pharmaceutical Research and Manufacturers of America (PhRMA) declined 2.4% in 2011 to an estimated $49,476 million. Domestic spending fell 5.3%, but foreign R&D rose 9.2% to make up 78% and 22% of R&D spending, respectively. As a percentage of sales, total R&D was 16.7%. Sales by […]
R&D expenditures by US universities grew 6.9% to $61.2 billion in fiscal 2010, according to a survey of 742 institutions that spend at least $150,000 on R&D annually. The one-time $2.7 billion boost from 2009’s American Recovery and Reinvestment Act increased the federal government’s share of university R&D spending to 61%. Of the $37.5 billion […]
Despite an anticipated transition to renewable energy technologies, reliance on fossil fuels remains strong due to prevalence and low cost. In 2011, the International Energy Agency (IEA) projected natural gas’s share of energy demand worldwide would reach 25% by 2035, up from 21% in 2010. The rise is largely credited to North America’s increasing dependence […]
Several recent attempts to reproduce scientific studies have failed. About 100 scientists under the direction of former Amgen researcher C. Glenn Begley found that 47 of 53 “landmark” academic cancer studies could not be reproduced. A decade ago, cancer drug discoveries were supported by as many as 200 publications, and the number of such papers […]
An Institute of Medicine (IOM) study on “omics” tests at Duke University has found that such tests are susceptible to errors. The initial investigation began in 2009, when biostatisticians at MD Anderson Cancer Center voiced concern over the published claims of two Duke scientists that molecular patterns in tumor cells could indicate patients’ reactions to […]
On March 27, the EPA proposed a first-time standard for carbon dioxide emissions from power plants. New power plants would have to emit less than 1,000 pounds of carbon dioxide annually per megawatt hour. The standard would not affect plants already in operation, plants that do not use fossil fuels or plants that will begin […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
